首页> 外文期刊>Seminars in Respiratory and Critical Care Medicine >Enterovirus D68 and Human Respiratory Infections
【24h】

Enterovirus D68 and Human Respiratory Infections

机译:肠道病毒D68和人类呼吸道感染

获取原文
获取原文并翻译 | 示例
           

摘要

Enterovirus D68 (EV-D68) is a member of the species Enterovirus D in the genus Enterovirus of the Picornaviridae family. EV-D68 was first isolated in the United States in 1962 and is primarily an agent of respiratory disease. Infections with EV-D68 have been rarely reported until recently, when reports of EV-D68 associated with respiratory disease increased notably worldwide. An outbreak in 2014 in the United States, for example, involved more than 1,000 cases of severe respiratory disease that occurred across almost all states. Phylogenetic analysis of all EV-D68 sequences indicates that the circulating strains of EV-D68 can be classified into two lineages, lineage 1 and lineage 2. In contrast to the prototype Fermon strain, all circulating strains have deletions in their genomes. Respiratory illness associated with EV-D68 infection ranges from mild illness that just needs outpatient service to severe illness requiring intensive care and mechanical ventilation. To date, there are no specific medicines and vaccines to treat or prevent EV-D68 infection. This review provides a detailed overview about our current understanding of EV-D68-related virology, epidemiology and clinical syndromes, pathogenesis, and laboratory diagnostics.
机译:肠道病毒D68(EV-D68)是Picornaviridae家族的肠道病毒的物种肠道病毒D的成员。 EV-D68于1962年首次分离在美国,主要是呼吸系统疾病的代理商。当与呼吸道疾病相关的EV-D68的报告显着增加,迄今为止,迄今为止,迄今为止已经很少报道eV-D68的感染。例如,2014年在美国爆发,涉及超过1,000例几乎所有国家发生的严重呼吸系统疾病。所有EV-D68序列的系统发育分析表明,EV-D68的循环菌株可以分为两个谱系,谱系1和谱系2.与原型Fermon菌株相反,所有循环菌株都缺失其基因组。与EV-D68感染相关的呼吸疾病来自轻度疾病,只需要门诊服务到需要重症监护和机械通气的严重疾病。迄今为止,没有特定的药物和疫苗治疗或预防EV-D68感染。此评论详细概述了我们目前对EV-D68相关病毒学,流行病学和临床综合征,发病机制和实验室诊断的理解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号